This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Goossens LMA, Standaert B, Hartwig N, Hövels AM, Al MJ.The cost-utility of rotavirus vaccination with Rotarix TM (RIX4414) in the Netherlands. Vaccine 26: 1118-1127, No. 8, 20 Feb 2008
Rights and permissions
About this article
Cite this article
Mass rotavirus vaccination “attractive” in The Netherlands. Pharmacoecon. Outcomes News 547, 3 (2008). https://doi.org/10.2165/00151234-200805470-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805470-00006